Springe direkt zu Inhalt

Collaboration with Bayer HealthCare

collaboration partner

collaboration partner

News from Aug 13, 2014

On August 1st the group started a research collaboration with Bayer HealthCare on the investigation of protein-ligand-binding. Aim of this project is to test the capability of native mass spectrometry to serve as a tool for the high throughput screening of pharmaceutically-relevant compounds. From now on, Melanies research will be focused on this topic.

99 / 100
masses4masses
v01
v02
twitter